Concepedia

Michael P. Sanderson

MP

Statistics

Publications

20

Citations

2K

H-Index

19

Active since

2004

Affiliations

Boehringer Ingelheim (Austria)(Current)

German Cancer Research Center

Merck KGaA, Darmstadt (Germany)

Boehringer Ingelheim (Germany)

Heidelberg University

Michael P. Sanderson is an author at Boehringer Ingelheim (Austria) specializing in life sciences, oncology, and molecular oncology.

ORCID

Publications per year

2004–2021

20

Publications

20

Target Binding Properties and Cellular Activity of Afatinib (BIBW 2992), an Irreversible ErbB Family Blocker

Flavio Solca, G. Dahl, Andreas Zoephel et al. · Journal of Pharmacology and Experimental Therapeutics · 2012 · 867 citations

, , +16

A role for exosomes in the constitutive and stimulus-induced ectodomain cleavage of L1 and CD44

Alexander Stoeck, Sascha Keller, Svenja Riedle et al. · Biochemical Journal · 2006 · 248 citations · Full text

, , +16

Generation of novel, secreted epidermal growth factor receptor (EGFR/ErbB1) isoforms via metalloprotease‐dependent ectodomain shedding and exosome secretion

Michael P. Sanderson, Sascha Keller, Ángel Alonso et al. · Journal of Cellular Biochemistry · 2007 · 118 citations

, , +16

ADAM10 Mediates Ectodomain Shedding of the Betacellulin Precursor Activated by p-Aminophenylmercuric Acetate and Extracellular Calcium Influx

Michael P. Sanderson, Sarah N. Erickson, Peter J. Gough et al. · Journal of Biological Chemistry · 2004 · 106 citations · Full text

, , +16

L1-CAM in a membrane-bound or soluble form augments protection from apoptosis in ovarian carcinoma cells

Alexander Stoeck, Daniela Gast, Michael P. Sanderson et al. · Gynecologic Oncology · 2006 · 94 citations

, , +13

1–5 of 20